BR0107709A - Monoidrato de cis-litio 4-ciano-4-[ 3-( ciclopentiloxi )-4-metoxifenil ] ciclohexanocarboxilato - Google Patents

Monoidrato de cis-litio 4-ciano-4-[ 3-( ciclopentiloxi )-4-metoxifenil ] ciclohexanocarboxilato

Info

Publication number
BR0107709A
BR0107709A BR0107709-0A BR0107709A BR0107709A BR 0107709 A BR0107709 A BR 0107709A BR 0107709 A BR0107709 A BR 0107709A BR 0107709 A BR0107709 A BR 0107709A
Authority
BR
Brazil
Prior art keywords
cyclopentyloxy
monohydrate
cis
cyano
cyclohexanecarboxylate
Prior art date
Application number
BR0107709-0A
Other languages
English (en)
Inventor
Kevin Scott Webb
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR0107709A publication Critical patent/BR0107709A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MONOIDRATO DE CIS-LITIO 4-CIANO-4-[3-(CICLOPENTILOXI)-4-METOXIFENIL] CICLOHEXANOCARBOXILATO". Essa invenção proporciona meios para a preparação de um monoidrato do sal de lítio de cis 4-ciano-4-[3-(ciclopentiloxi) -4-metoxifenil]ciclohexanocarboxilato, o que é uma nova composição de substância.
BR0107709-0A 2000-01-26 2001-01-18 Monoidrato de cis-litio 4-ciano-4-[ 3-( ciclopentiloxi )-4-metoxifenil ] ciclohexanocarboxilato BR0107709A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17812900P 2000-01-26 2000-01-26
PCT/US2001/001487 WO2001055094A1 (en) 2000-01-26 2001-01-18 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate

Publications (1)

Publication Number Publication Date
BR0107709A true BR0107709A (pt) 2002-11-19

Family

ID=22651319

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107709-0A BR0107709A (pt) 2000-01-26 2001-01-18 Monoidrato de cis-litio 4-ciano-4-[ 3-( ciclopentiloxi )-4-metoxifenil ] ciclohexanocarboxilato

Country Status (36)

Country Link
US (1) US6699903B2 (pt)
EP (1) EP1250313B1 (pt)
JP (1) JP2003520842A (pt)
KR (1) KR20020073183A (pt)
CN (1) CN1157371C (pt)
AP (1) AP1432A (pt)
AR (1) AR027273A1 (pt)
AT (1) ATE344235T1 (pt)
AU (1) AU3282201A (pt)
BG (1) BG106959A (pt)
BR (1) BR0107709A (pt)
CA (1) CA2397758A1 (pt)
CO (1) CO5300517A1 (pt)
CY (1) CY1108515T1 (pt)
CZ (1) CZ20022590A3 (pt)
DE (1) DE60124221T2 (pt)
DK (1) DK1250313T3 (pt)
DZ (1) DZ3285A1 (pt)
EA (1) EA200200791A1 (pt)
EG (1) EG24065A (pt)
ES (1) ES2273804T3 (pt)
HK (1) HK1051030A1 (pt)
HU (1) HUP0204150A3 (pt)
IL (1) IL150400A0 (pt)
MA (1) MA25652A1 (pt)
MX (1) MXPA02007300A (pt)
MY (1) MY122802A (pt)
NO (1) NO20023378L (pt)
NZ (1) NZ519799A (pt)
OA (1) OA12159A (pt)
PE (1) PE20011040A1 (pt)
PL (1) PL356832A1 (pt)
PT (1) PT1250313E (pt)
SK (1) SK10942002A3 (pt)
WO (1) WO2001055094A1 (pt)
ZA (1) ZA200205925B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011802D0 (en) * 2000-05-16 2000-07-05 Smithkline Beecham Method for enhancing cognitive function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225869B1 (en) * 1992-04-02 2007-11-28 Smithkline Beecham Corp Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
UA67753C2 (uk) * 1997-10-10 2004-07-15 Смітклайн Бічам Корпорейшн Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот

Also Published As

Publication number Publication date
PE20011040A1 (es) 2001-10-31
CN1157371C (zh) 2004-07-14
PL356832A1 (en) 2004-07-12
EP1250313A1 (en) 2002-10-23
IL150400A0 (en) 2002-12-01
DK1250313T3 (da) 2007-02-12
MY122802A (en) 2006-05-31
EP1250313B1 (en) 2006-11-02
MXPA02007300A (es) 2002-11-29
NO20023378D0 (no) 2002-07-12
BG106959A (en) 2003-05-30
CO5300517A1 (es) 2003-07-31
ES2273804T3 (es) 2007-05-16
AP1432A (en) 2005-06-20
DE60124221D1 (de) 2006-12-14
EG24065A (en) 2008-05-08
HUP0204150A3 (en) 2003-05-28
CN1395556A (zh) 2003-02-05
WO2001055094A1 (en) 2001-08-02
NZ519799A (en) 2004-04-30
CY1108515T1 (el) 2014-04-09
DZ3285A1 (fr) 2001-08-02
US20030032670A1 (en) 2003-02-13
AP2002002566A0 (en) 2002-06-30
MA25652A1 (fr) 2002-12-31
NO20023378L (no) 2002-07-12
HUP0204150A2 (hu) 2003-04-28
JP2003520842A (ja) 2003-07-08
EP1250313A4 (en) 2005-09-21
SK10942002A3 (sk) 2002-11-06
PT1250313E (pt) 2007-01-31
HK1051030A1 (zh) 2003-07-18
ATE344235T1 (de) 2006-11-15
DE60124221T2 (de) 2007-09-13
AU3282201A (en) 2001-08-07
US6699903B2 (en) 2004-03-02
AR027273A1 (es) 2003-03-19
CZ20022590A3 (cs) 2003-01-15
EA200200791A1 (ru) 2002-12-26
ZA200205925B (en) 2003-11-21
KR20020073183A (ko) 2002-09-19
CA2397758A1 (en) 2001-08-02
OA12159A (en) 2006-05-08

Similar Documents

Publication Publication Date Title
GT200000108A (es) Procedimiento para la obtencion de composiciones antibacteriales.
ES2160534B1 (es) Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
BR0114896A (pt) Preparação contendo nateglinida, e, método para produzir a mesma
ATE369848T1 (de) Verwendung von d-serine oder d-alanine zur behandlung von schizophrenie
BR9912029A (pt) Compostos reacionais de amina compreendendo um ou mais ingredientes ativos
BRPI0412684A (pt) compostos ppar-ativos
GR3019122T3 (pt)
ES2190164T3 (es) Compuestos piretroides y composiciones que los contienen para controlar plagas.
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
IS1954B (is) Alfa-hýdroxý, -amínó- og -flúoró afleiður beta-súlfonýlhýdroxamsýra notaðar sem tálmar við grindarmálmprótínkljúfum
BRPI0417714A (pt) composto, composição farmacêutica, e, uso de um composto
BR0204678A (pt) Inibidor de nf-kb contendo derivado de ácido benzóico substituìdo como ingrediente ativo
CR9385A (es) Agente preventivo o terapeutico para el desorden de la depresion o la ansiedad
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
BR0212931A (pt) Composição farmacêutica de liberação prolongada contendo metformina
BR0110689A (pt) Composição fungicida, e, métodos para intensificar a atividade fungicida de etaboxam, e para controlar fitopatógenos indesejados
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
ES2305567T3 (es) Formulaciones de tramadol de liberacion sostenida con una eficacia de 24 horas.
BR9812085A (pt) "método para a sìntese de derivados de quinolina"
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
PA8483301A1 (es) Concentrado oral de sertralina
PT1128829E (pt) Associacao de riluzole e de alfa-tocoferol
AR043134A1 (es) Agentes de despigmentacion
BRPI0413718A (pt) ativadores de plasminogênio tendo uma capacidade reduzida de ligar lisina
AP1432A (en) Monohydrate of Cis-Lithium-Cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A, 9A E 10A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.